Primary Care Diabetes
Volume 2, Issue 4 , Pages 195-199 , December 2008

Use of hormonal contraceptive methods by women with diabetes

  • Jill Shawe

      Affiliations

    • University of Surrey, Stag Hill, Guildford GU2 7TE, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 1483 684541.
    • ,
  • Henrietta Mulnier

      Affiliations

    • Postgraduate Medical School, University of Surrey, Daphne Jackson Road, Manor Park, Guildford GU2 7WG, UK
    • ,
  • Peter Nicholls

      Affiliations

    • School of Nursing & Midwifery, University of Southampton, University Road, Highfield, Southampton SO17 1BJ, UK
    • ,
  • Ross Lawrenson

      Affiliations

    • Peter Rothwell Academic Centre, Waikato Hospital, Private Bag 3200, Hamilton 3204, New Zealand

Received 13 March 2008 ,Revised 15 October 2008 ,Accepted 16 October 2008.

References 

  1. CEMACH Confidential Enquiry into Maternal & Child Health: Pregnancy in women with type 1 & type 2 diabetes in 2002–2003, England Wales & Northern Ireland CEMACH, London, 2005.
  2. Macintosh M, Fleming K, Bailey J, Doyle P, Modder J, Acolet D, et al. Perinatal mortality & congenital abnormalities in babies of women with tyoe 1 or type 2 diabetes in England Wales & Northern Ireland: population based study. BMJ. 2006;333:7560
  3. CEMACH Confidential Enquiry into Maternal & Child Health: Diabetes in pregnancy: are we providing the best care? Findings of a national enquiry CEMACH, London, 2007.
  4. WHO improving access to quality care in family planning, medical eligibility criteria for contraceptive use, WHO. http://www.who.int/reproductive-health/publications/mec/, 2004 (accessed 1st October 2007).
  5. Girling J, de Swiet M. Contraception for women with diabetes or hypertension. Trends in Urology Gynaecology & Sexual Health. 1997;2(8):23–33
  6. Swerdlow AJ, Jones ME. Mortality during 25 years of follow-up of a cohort with diabetes. International journal of Epidemiology. 1996;25:1250–1261
  7. Lawrenson RA, Leydon GM, Williams TJ, Newson RB, Feher MD. Patterns of contraception in UK women with Type 1 diabetes: a GP database study. Diabetic Medicine. 1999;16:395–399
  8. Office for National statistics (ONS) Key Health statistics from General Practice 1998, Series MB6 No. 2 2000, Office National Statistics, London, 2000.
  9. Lawrenson R, Todd JC, Leydon GM, Williams TJ, Farmer RD. Validation of the diagnosis of venous thromboembolism in general practice database studies. British Journal of Clinical Pharmacology. 2000;49(6):591–596
  10. Walley T, Mantgani A. The UK General Practice Research Database Lancet. 1997;350(9084):1097–1099
  11. Hollowell J. The General Practice Research Database: quality of morbidity data. Population Trends. 1997;87:36–40
  12. British National Formulary British Medical Association & Royal Pharmaceutical Society Great Britain BMJ and RPS Publishing, London, 2007.
  13. SPSS Inc. 12.0 for Windows, Chicago, IL, 2003.
  14. F. Dawe, L. Rainford, Contraception and sexual health 2003. A report on research using the ONS Omnibus Survey produced by the Office for National Statistics on behalf of the Department of Health, London, Office for National Statistics (2004), www.statistics.gov.uk (accessed 31 October 2008).
  15. Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM. High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. Diabetes Care. 2006;29(April (4)):798–804
  16. Mulnier HE, Seaman HE, Raleigh VS, Soedamah-Muthu SS, Colhoun HM, Lawrenson RA, et al. Risk of myocardial infarction in men and women with type 2 diabetes in the UK: a cohort study using the General Practice Research Database. Diabetologia. 2008;51(September (9)):1639–1645
  17. Gibb D, Hockey S, Brown LJ, Lunt H. Attitudes and knowledge regarding contraception and pre-pregnancy counselling in insulin dependent diabetes. New Zealand Medical Journal. 1994;107:484–486
  18. Manolopoulos K, Kiess W, Braems GA, Deligeoroglou E, Creatsas G, Michalas S, et al. Which contraceptive methods are recommended for young women with type 1 diabetes mellitus? A survey among gynaecologists in Greece. European Journal of Obstetrics, Gynaecology, & Reproductive Biology. 2001;99(2):232–237
  19. Yang YX, Hennessy S, Lewis JD. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology. 2004;127(October (4)):1044–1050
  20. Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE, Colditz GA, et al. Nurses’ Health Study. Type 2 diabetes and subsequent incidence of breast cancer in the Nurses’ Health Study. Diabetes Care. 2003;26(June (6)):1752–1758
  21. Swerdlow AJ, Laing SP, Qiao Z, Slater SD, Burden AC, Botha JL, et al. Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. British Journal of Cancer. 2005;92(June 6 (11)):2070–2075
  22. Beral V, Doll R, Hermon C, Peto R, Reeves G. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet. 2008;371(January 26 (9609)):303–31415
  23. Huber JC, Bentz EK, Ott J, Tempfer CB. Non-contraceptive benefits of oral contraceptives. Expert Opinion on Pharmacotherapy. 2008;9(September (13)):2317–2325
  24. Mestman JH, Schmidt Sarosi C. Diabetes mellitus and fertility control: contraception management issues. American Journal of Obstetrics and Gynecology. 1993;168:2012–2020
  25. Steel JM. Pregnancy counseling and contraception in the insulin-dependent diabetic patient. Clinical Obstetrics and Gynaecology. 1985;28(3):553–566
  26. Royal College of General Practitioners RCOG . Oral contraceptive study. Lancet. 1977;2:727–731
  27. Lopez LM, Grimes DA, Schulz KF, Curtis KM. Steroidal contraceptives: effect on bone fractures in women. Cochrane Database System Review. 2006;18(October (4)):CD006033
  28. Shawe J, Lawrenson R. Hormonal contraception for women with diabetes mellitus: special considerations. Treatments in Endocrinology. 2003;2(5):321–330
  29. Heinemann LA, Lewis MA, Thorogood M, Spitzer WO, Guggenmoos-Holzmann I, Bruppacher R. Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women. BMJ. 1997;315(December 6 (7121)):1502–1504
  30. Seaman HE, de Vries CS, Farmer RD. The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case-control study. Human Reproduction. 2003;18(March (3)):522–526

PII: S1751-9918(08)00104-6

doi: 10.1016/j.pcd.2008.10.003

Primary Care Diabetes
Volume 2, Issue 4 , Pages 195-199 , December 2008

Article Tools